Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 98Leukemia, Myeloid, Acute 95Lymphoma, Non-Hodgkin 93Multiple Myeloma 92Leukemia 91Lymphoma, Large B-Cell, Diffuse 90Lymphoma 90Leukemia, Lymphocytic, Chronic, B-Cell 89Lymphoma, Follicular 84Hodgkin Disease 84Lymphoma, Large-Cell, Immunoblastic 75Lymphoma, Mantle-Cell 74Burkitt Lymphoma 67Myelodysplastic Syndromes 64Lymphoma, B-Cell, Marginal Zone 60Leukemia, Myeloid, Chronic-Phase 55Leukemia, Myeloid, Accelerated Phase 55Congenital Abnormalities 51Neoplasms, Plasma Cell 49Myeloproliferative Disorders 49Blast Crisis 44Leukemia, Myelomonocytic, Chronic 42Waldenstrom Macroglobulinemia 41Recurrence 37Primary Myelofibrosis 32Lymphoma, T-Cell, Cutaneous 32Anemia, Refractory, with Excess of Blasts 29Sezary Syndrome 28Mycosis Fungoides 28Breast Neoplasms 28

Interventions

Cyclophosphamide 3Vincristine 2Prednisone 2Etoposide 2Doxorubicin 2Brentuximab Vedotin 2romidepsin 1prednylidene 1fludarabine phosphate 1fludarabine 1deltacortene 1Vorinostat 1Salvia hispanica seed extract 1Receptors, Chimeric Antigen 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1MLN 8237 1Lenalidomide 1Lactones 1Ki-1 Antigen 1Ifosfamide 1Diet, Gluten-Free 1Depsipeptides 1Carboplatin 1Bortezomib 1Automobiles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Enteropathy-Associated T-Cell Lymphoma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT02561273 2023-12-13

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

University of Nebraska

Phase 1/2 Completed
54 enrolled 14 charts
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡